Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 58.05% |
| 2 | Technology | 7.69% |
| 3 | Financials | 6.83% |
| 4 | Healthcare | 6.42% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Virgin Galactic
SPCE
$455M
| $9.42M | 0.01% |
18,609
-16,407
| -47% | -$9.74M |
|
|
ACH
2102
Accendra Health
ACH
$93.1M
| $9.41M | 0.01% |
300,900
+202,365
| +205% | +$7.96M |
|
|
WPRT
2103
Westport Fuel Systems
WPRT
$35.1M
| $9.41M | 0.01% |
286,056
+7,951
| +3% | +$320K |
|
|
HYZN
2104
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
| $9.41M | 0.01% |
27,122
+17,547
| +183% | +$7.6M |
|
2105
TechTarget
TTGT
$283M
| $9.4M | 0.01% |
114,116
+65,481
| +135% | +$5.2M |
|
|
KDMN
2106
DELISTED
Kadmon Holdings, Inc.
KDMN
| $9.38M | 0.01% |
1,077,283
-4,120,315
| -79% | -$23.5M |
|
|
GIG
2107
DELISTED
GigCapital4, Inc. Common stock
GIG
| $9.38M | 0.01% |
951,299
+534,738
| +128% | +$5.26M |
|
2108
CALL
Sonos
SONO
$1.79B
| $9.37M | 0.01% |
289,500
+274,500
| +1,830% | +$9.89M |
|
|
RONI.U
2109
DELISTED
Rice Acquisition Corp. II Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
RONI.U
| $9.36M | 0.01% |
908,934
+7,496
| +0.8% | +$76.4K |
|
2110
CALL
Automatic Data Processing
ADP
$113B
| $9.34M | 0.01% |
46,700
+38,100
| +443% | +$7.85M |
|
|
ALE
2111
DELISTED
Allete
ALE
| $9.34M | 0.01% |
156,830
-23,230
| -13% | -$1.57M |
|
2112
PUT
Penumbra
PEN
$12.6B
| $9.33M | 0.01% |
35,000
-6,400
| -15% | -$1.72M |
|
2113
Jackson Financial
JXN
$9.04B
| $9.33M | 0.01% |
+358,709
| New | +$9.76M |
|
2114
Seneca Foods Class A
SENEA
$1.3B
| $9.32M | 0.01% |
193,322
-3,368
| -2% | -$170K |
|
|
KRNL
2115
DELISTED
Kernel Group Holdings, Inc. Class A Ordinary Shares
KRNL
| $9.31M | 0.01% |
955,950
+694,875
| +266% | +$6.73M |
|
2116
Equinor
EQNR
$98.6B
| $9.3M | 0.01% |
364,905
-740,558
| -67% | -$15.9M |
|
2117
iShares Core S&P Small-Cap ETF
IJR
$111B
| $9.3M | 0.01% |
85,201
+50,085
| +143% | +$5.51M |
|
2118
Zoom
ZM
$29.4B
| $9.3M | 0.01% |
35,570
-47,090
| -57% | -$15.9M |
|
|
LOVE
2119
LoveSac
LOVE
$235M
| $9.3M | 0.01% |
140,689
+134,530
| +2,184% | +$8.43M |
|
2120
Masco
MAS
$14.4B
| $9.29M | 0.01% |
167,271
+158,763
| +1,866% | +$9.42M |
|
2121
CVRx
CVRX
$81M
| $9.29M | 0.01% |
561,653
+277,568
| +98% | +$5.32M |
|
2122
BancFirst
BANF
$3.71B
| $9.27M | 0.01% |
154,131
+77,981
| +102% | +$4.46M |
|
2123
Phreesia
PHR
$733M
| $9.27M | 0.01% |
150,162
-129,172
| -46% | -$8.62M |
|
2124
Protagonist Therapeutics
PTGX
$9.67B
| $9.27M | 0.01% |
522,871
+507,431
| +3,286% | +$21.6M |
|
2125
CALL
Canadian Natural Resources
CNQ
$103B
| $9.26M | 0.01% |
+408,400
| New | +$6.72M |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander's Q3 2021 filing shows 1,245 new, 2,719 increased, 2,446 reduced and 981 closed positions. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M. The largest sale was Alexion Pharmaceuticals, an estimated $887M.
By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, up from 55% a quarter earlier, followed by Technology and Financials.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.